Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians
Open Access
- 4 January 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 26 (5), 546-550
- https://doi.org/10.1007/s11606-010-1609-1
Abstract
The current emphasis on comparative effectiveness research will provide practicing physicians with increasing volumes of observational evidence about preventive care. However, numerous highly publicized observational studies of the effect of prevention on health outcomes have reported exaggerated relationships that were later contradicted by randomized controlled trials. A growing body of research has identified sources of bias in observational studies that are related to patient behaviors or underlying patient characteristics, known as the healthy user effect, the healthy adherer effect, confounding by functional status or cognitive impairment, and confounding by selective prescribing. In this manuscript we briefly review observational studies of prevention that have appeared to reach incorrect conclusions. We then describe potential sources of bias in these studies and discuss study designs, analytical methods, and sensitivity analyses that may mitigate bias or increase confidence in the results reported. More careful consideration of these sources of bias and study designs by providers can enhance evidence-based decision-making.Keywords
This publication has 38 references indexed in Scilit:
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims DataEpidemiology, 2009
- Statin Adherence and Risk of AccidentsCirculation, 2009
- Improving the Prediction of Medication ComplianceMedical Care, 2009
- Statins and fracture risk. A systematic reviewPharmacoepidemiology and Drug Safety, 2007
- Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort studyBMJ, 2006
- A meta-analysis of the association between adherence to drug therapy and mortalityBMJ, 2006
- Evaluating Short-Term Drug Effects Using a Physician-Specific Prescribing Preference as an Instrumental VariableEpidemiology, 2006
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart DiseaseThe New England Journal of Medicine, 1985